Nipro Corp., a leader in the healthcare industry based in Japan, has a low-risk ESG score of 19.4. Specializing in medical devices, Nipro Corp. offers a variety of products in segments such as medical, pharmaceutical, glass, and other. With a focus on dialysis and artificial organs, their medical segment holds the largest revenue contribution. The company also provides products related to injections, infusions, renal treatments, diabetes, and generic drugs. Operating primarily in Japan, Nipro Corp. is a trusted name in the healthcare industry.